Prof Chris Packard reviews the latest evidence showing that triglyceride-rich lipoproteins and their remnants can initiate and progress atherogenesis, and discusses the potential of novel and existing agents in regulating remnant lipoproteins.
Educational partners and supporters (others pending)
